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http://dx.doi.org/10.1016/j.jmii.2012Background/Objective: The IL-12eIFN-g axis is critical for immune defense against mycobac-
terial infections. Inherited mutations that affect normal activation of this self-amplifying cyto-
kine reaction lead to increased chances of mycobacterial infections, known as Mendelian
susceptibility to mycobacterial diseases (MSMD). Delayed diagnosis and difficulty in identifying
pathogenic mycobacteria hinder proper treatment of patients, so the aim of this study was to
facilitate the diagnosis of mycobacterial infections in MSMD patients using an oligonucleotide
array method.
Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from three MSMD patients
in the same family. A series of immunologic studies, including testing for cytokine secretion
after leukocyte stimulation, cell-surface marker analysis, and cDNA sequencing, were then
performed. An oligonucleotide array was used to rapidly identify pathogens.
Results: Cytokine secretion testing showed normal IFN-g secretion after IL-12 stimulation but
low IL-12 secretion after IFN-g stimulation, which indicates a defect in the IFN-g receptor or its
intracellular signaling. Cell-surface receptor analysis showed IFN-g receptor 1 overexpression,
suggesting an autosomal dominant IFN-g receptor 1 deficiency. cDNA sequencing identified the
IFNGR1 818del4 mutation in three members of the family with known MSMD, and an oligonucle-
otide array identified Mycobacterium tuberculosis complex and Mycobacterium abscessus as
pathogens.Clinical Medicine, National Cheng-Kung University, 138 Sheng-Li Road, Tainan 70403, Taiwan.
edu.tw (C.-C. Shieh).
ted equally to this work.
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.08.017
412 L.-H. Wang et al.Conclusions: Patients with suspected MSMD should undergo molecular diagnosis of the primary
immunodeficiency. Oligonucleotide array methods may be a tool for rapid identification of
pathogens and for guiding antimicrobial treatment in immunodeficient patients.
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reserved.Introduction
Severe infections caused by low-virulence mycobacteria,
including Bacillus CalmetteeGue´rin (BCG) and environ-
mental non-tuberculous mycobacteria (NTM), often occur
in patients with several types of primary immunodeficiency.
It has been reported that gene mutations leading to severe
combined immunodeficiency (SCID), chronic granulomatous
disease (CGD), hyper-IgE syndrome, and a defective inter-
feron-g (IFN-g)eIL-12 axis cause increased susceptibility to
mycobacteria.1,2 Different from people with other primary
immunodeficiencies, patients with defects in the IFN-geIL-
12 axis, termed Mendelian susceptibility to mycobacterial
diseases (MSMD), are particularly susceptible to mycobac-
terial or salmonella infections, while other infections are
relatively rare.3
Treatment for mycobacterial infections in MSMD patients
depends on early identification of the infecting microor-
ganisms and effective antibiotic treatment. However, early
diagnosis of the causative microorganisms in these patients
can be difficult because isolation of mycobacteria by
culture may take up to weeks and is often unsuccessful.4e6
A strategy for rapid identification of the infecting micro-
organisms is therefore crucial for treatment of this group of
immunocompromised patients with frequent and severe
mycobacterial infections.
Here, we report the molecular characterization of three
MSMD patients from the same family. Each of them suffered
from different mycobacterial infections. Using the oligo-
nucleotide array method, we identified the infectious
mycobacteria in two of the patients and successfully
treated them based on the results.
Patients and methods
The proband was a male infant (Patient 1). His older sister
(Patient 2) and his mother (Patient 3) were found to have
the same disease-causing mutation (Fig. 1A).
Patient 1
A 6-month-old boy was referred to our hospital due to fever
and severe cough with profuse sputum for 1 month. Phys-
ical examination on admission revealed a febrile and
acutely ill-looking infant with tachypnea. Chest ausculta-
tion showed bilateral crackles. Palpation revealed hep-
atosplenomegaly. Generalized erythematous papules were
found all over the body surface (Fig. 1B). BCG vaccine was
given 5 months before admission shortly after his birth. An
unhealed BCG vaccination wound over the left upper arm
(Fig. 1C) and left axillary lymphadenopathy were found. Achest X-ray (CXR) examination showed diffuse bilateral
pulmonary nodular infiltrates (Fig. 1D). Acid-fast staining of
gastric lavage fluid, sputum, and skin biopsy showed the
presence of bacilli. Mycobacterial culture was negative
after 8 weeks. The absolute numbers and ratios for his
lymphocyte subpopulations were within normal limits.
Normal respiratory burst was found in his stimulated
phagocytic leukocytes. Immunological study and gene
sequencing revealed that the patient had a disease-causing
mutation on the gene encoding IFN-g receptor 1. An
oligonucleotide array method was used to identify the
mycobacteria in a skin biopsy sample. His clinical condition
gradually improved after anti-M. tuberculosis complex
treatments including isoniazid, rifampin, ciprofloxacin, and
amikacin. CXR examination showed clearance of the lung
lesions 2 months after the anti-mycobacterial treatment
was started (Fig. 1E). The patient is currently on antibiotic
and IFN-g treatment and shows normal growth and
development.
Patient 2
A 19-month-old girl who had suffered from recurrent fever
for 3 weeks was referred to our hospital 9 years ago. A
gallium inflammation scan and magnetic resonance imaging
(MRI) revealed osteomyelitis over L1e2 and L5 (Fig. 1F).
After empiric antibiotic treatment for 8 weeks, intermit-
tent mild fever persisted. Follow-up laboratory data and
MRI revealed no improvement in her osteomyelitis. Acid-
fast staining of a bone biopsy showed the presence of
bacilli, so antituberculosis drug therapy was initiated with
isoniazid, rifampin, pyrazinamide, and ethambutol. Myco-
bacterial culture revealed Mycobacterium avium complex
12 weeks later. We then changed the anti-mycobacterial
drugs to clarithromycin and rifampin. The patient’s clin-
ical condition gradually improved after the above treat-
ment. cDNA sequencing revealed the same disease-causing
mutation (Fig. 1A) as in Patient 1. She is currently on
prophylactic antibiotic treatment with azithromycin.
Genetic counseling on the autosomal dominant (AD) inher-
itance was provided for the family.
Patient 3
A 35-year-old woman had an enlarging wound (size on
examination, 8 8 cm2) on her right knee for 8 years
(Fig. 1G). She had been given many different treatments,
including empiric antibiotics, wound debridement,
hyperbaric oxygen therapy, and skin grafting, before she
presented at our hospital. Wound biopsies revealed
granulomatous inflammation. However, acid-fast staining
and mycobacterial culture produced negative results
Figure 1. Clinical characteristics of patients with MSMD. (A) Pedigree of this family. (B) Multiple erythematous papules on the
left leg of Patient 1. (C) An unhealed BCG vaccination wound on the left arm of Patient 1. (D) Diffuse bilateral pulmonary nodular
infiltrates in the CXR of Patient 1. (E) Improvement in CXR findings after 2 months of anti-BCG treatment of Patient 1. (F) Multiple
vertebral osteomyelitis over L1e2 and L5 (shown by arrows) in MRI results for Patient 2. (G) A large and difficult-to-heal wound on
the right knee of Patient 3. (H) The wound improved after 2 months of antibiotic treatment against Mycobacterial abscessus.
Molecular diagnosis of mycobacterial susceptibility 413repeatedly. After Mycobacterium abscessus was identified
by an oligonucleotide array, she was treated with azi-
thromycin and ciprofloxacin, along with IFN-g therapy.
cDNA sequencing revealed the same disease-causing
mutation as in Patients 1 and 2. The wound condition
gradually improved, with apparent granulation tissue
formation on the central area and scar formation on the
margin 2 months after initiation of the treatment
(Fig. 1H).Stimulated cytokine production by peripheral
blood mononuclear cells
Peripheral blood mononuclear cells (PBMCs) from healthy
control individuals and patients were obtained by gradient
centrifugation of peripheral blood on Ficoll-paque (GE
Healthcare, Piscataway, NJ, USA). Separated PBMCs were
prepared at 1 106/mL in RPMI1640 with 10% fetal bovine
serum (FBS; Gibco, Grand Island, NY, USA). The cells were
414 L.-H. Wang et al.then stimulated with phytohemagglutinin (PHA, 1%; Sigma,
St. Louis, MO, USA) or lipopolysaccharide (LPS, 200 ng/mL;
Sigma) with or without IL-12 (1 ng/mL; ProSpec-Tany
TechnoGene, Rehovot, Israel) or IFN-g (1000 U/mL;
ProSpec-Tany TechnoGene). Supernatants were collected
after 48 hours of incubation at 37C and stored at 20C
before cytokine detection.
Anti-cytokine autoantibody detection
Plasma samples from healthy control individuals and
patients were diluted 50 and 5000 times and incubated 1:1
with fixed concentrations of recombinant IL-12 and IFN-g at
37C for 1 hour. IL-12 and IFN-g levels were detected using
a Bio-plex cytokine assay (Bio-Rad, Hercules, CA, USA)
system and a Luminex 200 analyzer (Luminex, Austin, TX,
USA).
Cytokine determination
Bio-plex cytokine assays were used to determine cytokine
levels in supernatants from PBMC stimulation or anti-
cytokine autoantibody detection experiments. IL-12, IFN-g,
TNF-a, IL-1b and IL-6 were detected. In brief, supernatants
were incubated with beads coupled to anti-cytokine
capture antibodies. After 30 minutes of incubation and
a washing procedure, the beads were incubated with
detection antibodies for another 30 minutes. Finally, the
beads were labeled with streptavidin-PE and then analyzed
on a Luminex 200 analyzer.
Cell-surface IFNGR1 (CD119) expression
Detection of IFNGR1 by flow cytometry on fresh blood cells
was performed using a carboxyfluorescein (CFS)-conjugated
mouse anti-CD119 monoclonal antibody (R&D, Minneapolis,
MN, USA). Whole blood samples were treated with BD Lysing
Solution (BD Biosciences, San Diego, CA, USA) and then
incubated with 10 mL of antibody at 4C for 30 minutes.
After incubation, unreacted antibody was removed by
washing the cells twice with ice-cold phosphate buffer
solution (PBS). As a control, cells in a separate tube were
treated with non-binding fluorescein-labeled mouse IgG1
antibody.
Gene sequencing
Polymerase chain reaction (PCR) of the IFNGR1 cDNA coding
region was performed and the PCR products were directly
sequenced by the Center for Genomic Medicine of National
Cheng Kung University.
DNA extraction
DNA was extracted from tissue biopsies obtained from the
patients. Six paraffin sections were dissolved in 1 mL of
xylene and centrifuged at 12,000 rpm for 10 minutes. The
pellet was washed with 1 mL of absolute alcohol and then
centrifuged at the same speed for 10 minutes. DNAs in
the resulting precipitate and in the tissue biopsy wereextracted with a Qiagen DNeasy Blood and Tissue kit
(Hilden, Germany) according to the manufacturer’s
instructions.
Identification of mycobacteria by oligonucleotide
array
A membrane array (Blue Point, Sancordon Co., Taichung,
Taiwan) was used to identify mycobacteria in the extracted
DNA according to the manufacturer’s instructions. The
array was capable of identifying Mycobacterium tubercu-
losis complex and 21 NTM species. The procedures of array
hybridization consisted of PCR amplification of a region of
the rRNA operon, hybridization of the digoxigenin-labeled
amplicon to probes on the array, and then reaction with
enzyme-conjugated anti-digoxigenin antibodies and
enzyme substrate. The hybridized spot (0.4 mm in diam-
eter) was read by the naked eye. An isolate was identified
to the species level with the positive control probe
(mycobacteria-specific) and species-specific probe (or
probes) being hybridized at the same time.
Results
PBMCs from our patients secreted low levels of IL-
12 and TNF-a after IFN-g stimulation
We investigated IL12- or IFN-g-induced cytokine secretion
by activated PBMCs from our patients. IL-12 stimulation
induced equivalent IFN-g secretion by PHA-activated cells
from our patients and healthy control individuals (Fig. 2A).
However, IFN-g stimulation did not effectively induce IL-12
or TNF-a secretion in LPS-treated PBMCs from the patients,
while cells from healthy control individuals produced higher
amounts of IL-12 or TNF-a (Fig. 2B and C). By contrast, IL-6
secretion after LPS and IFN-g stimulation was equivalent in
cells from the patients and the control individuals (Fig. 2D).
These findings indicate that IFN-g-induced PBMCs activa-
tion was defective in our patients.
It has been reported that an auto-antibody against IFN-g
is a cause of susceptibility to NTM infection,7e10 so we
tested serum for auto-antibodies against IL-12 (Fig. 2E) and
IFN-g (Fig. 2F). We diluted serum samples 100 or 10,000
times with PBS and measured their activity for neutraliza-
tion of IFN-g or IL-12 recombinant proteins. Serum from
a patient with strong neutralizing activity against IFN-g, as
previously reported,11 was used as a positive control
(Fig. 2E and F). We did not find significant neutralizing
activity in serum samples from healthy control individuals
and our patients. These findings indicate that the suscep-
tibility to NTM infection observed in our patients is probably
due to an intrinsic defect in IFN-g-induced leukocyte
activation.
Cell-surface receptor expression and molecular
diagnosis revealed that the patients have an AD
IFNGR1 mutation
We analyzed IFNGR1 (CD119) expression on monocytes from
our patients by flow cytometry. CD119 levels were higher in
Figure 2. Abnormal cytokine secretion by activated leukocytes of patients due to intrinsic defects on immune cells. Peripheral
blood mononuclear cells were isolated from normal control individuals and patients. Cytokine secretion ability with or without IL-
12 and IFN-g stimulation was investigated. (A) IFN-g secretion was measured after stimulation with or without 1% phytohemag-
glutinin (PHA) and/or IL-12 (1 ng/mL). (B) IL-12, (C) TNF-a and (D) IL-6 secretion was measured after stimulation with or without
lipopolysaccharide (LPS, 200 ng/mL) and/or IFN-g (1000 U/mL). We also tested whether anti-cytokine autoantibodies were present
in sera by diluting serum samples 100 or10,000 times and measured their activity to neutralize (E) IL-12 or (F) IFN-g. A serum sample
from a patient previously reported to have anti- IFN-g autoantibodies was used as a positive control (F). The patterns of columns
representing control individuals and patients are shown in panel B. The experiments were repeated twice with similar results
(healthy control individuals, nZ 3).
Molecular diagnosis of mycobacterial susceptibility 415patients than in healthy control individuals (Fig. 3A). This
finding is consistent with previous reports of patients with
an AD IFNGR1 deficiency.12 We then sequenced the
complete cDNA of the IFNGR1 gene and found a deletion of
four nucleotides in exon 6, designated 818del4, which leads
to a truncated IFNGR1 peptide (Fig. 3B).
Oligonucleotide array for Mycobacterium species
identification
In the two recently infected patients, we used an oligonu-
cleotide array method to detect and identify mycobacteriain their tissues. M. tuberculosis complex was identified in
skin biopsy tissue (paraffin sections) from Patient 1. M.
abscessus was identified in wound biopsy tissue from
patient 3 (Fig. 4).
Discussion
Our three patients with MSMD were infected by different
atypical mycobacteria due to an inherited defect in
response to IFN-g. Their different clinical courses high-
lighted the difficulty in clinical decision-making in patients
with primary immunodeficiencies. Even when a genetic
Figure 3. The defective response to IFN-g in leukocytes from
the patients is due to a mutation in IFN-g receptor 1. (A)
Peripheral blood mononuclear cells were isolated from normal
control individuals and the patients. Surface expression of
CD119 was analyzed by CD119-CFS cell surface staining and
flow cytometry. A histogram profile for cells from Patient 1 is
shown. Similar results were found for cells from Patients 2 and
3. (B) Sequencing of cDNA revealed a small deletion (818del4)
in one allele of IFNGR1 exon 6, which leads to dual signals after
nucleotide 818. Similar results were found for samples from
Patients 2 and 3.
416 L.-H. Wang et al.diagnosis of MSMD is made, timely microorganism identifi-
cation, which is essential for effective infection control,
can be a difficult and time-consuming process. In this family
with an AD IFNGR1 mutation, the present study underscores
use of the oligonucleotide array method to determine the
pathogenic microorganism.
Gene mutations leading to MSMD have been found in
genes encoding IFNGR1, IFNGR2, IL-12B, IL-12RB1, NF-kBFigure 4. Mycobacteria in tissue samples were identified with an
from the patients were tested using a mycobacterial oligonucleotid
arrows indicate positive hybridization signals on the arrays. Dots
sponding to Mycobacterium spp. are indicated.essential modulator (NEMO), and signal transducer and
activator of transcription-1 (STAT1), which are all crucial
for the IL-12eIFN-g axis.3 We showed that the gene muta-
tion leading MSMD in our patients is an AD IFNGR1 deficiency
caused by a small deletion of four nucleotides in a mutation
hotspot.13 This gene mutation leads to a premature stop
codon in the proximal intracellular domain and produces
a truncated receptor peptide lacking the domains for signal
transduction and receptor recycling. Consequently, leuko-
cytes from these patients showed a three- to fivefold
increase in IFNGR1 (CD119) expression in flow cytometry
analysis. The more abundant mutant IFNGR1 pairs with
itself other or wild-type IFNGR1 and inhibits the signals
triggered by IFN-g in a dominant-negative manner.13,14
Two key points are crucial for successful treatment of
MSMD. First, the gene mutations responsible for the
defective immunity against mycobacterial infection should
be identified through effective differential diagnoses and
laboratory examinations. A newly characterized disease
entity with anti-cytokine autoantibodies that lead to
susceptibility to NTM infections has been reported in
several groups, including our own.7,10,11 An anti-IFN-g
autoantibody inhibits the IFN-g-mediated immune response
against mycobacteria and leads to severe NTM infections in
patients, especially those of Southeast Asian origin. The
present study started by excluding the possibility of the
presence of anti-cytokine autoantibody in our patients by
performing cytokine neutralization assays (Fig. 2E and F)
before pinpointing the defect in IFNGR1.
Since IFN-g is critical for macrophage activation, the
failure of infected macrophages to kill intracellular
bacteria in patients with MSMD may play an important role
in the particular susceptibility to mycobacteria. However,
IFNGR is also expressed on lymphocytes and other immune
cells. The production of other cytokines and small-molecule
mediators, including reactive oxygen species (ROS) and
reactive nitrogen species (RNS), which are sensitive to IFN-
g stimulation and crucial for defense against mycobac-
teria,15,16 may also be responsible for the immune defects.
In other MSMD gene mutations such as IL-12p40 deficiency
and STAT1 deficiency, the involvement of different leuko-
cyte populations and cytokines, including IL-17, may
complicate the immunodeficiency in these patients and
change the spectrum of infections.17,18 Molecular diagnosis
of the immunodeficiency should therefore be performed as
one of the top priorities in patients with suspected MSMD.19oligonucleotide array test. DNAs extracted from tissue samples
e array. (A) Negative control. (B) Patient 1. (C) Patient 3. The
in the first row and column are position markers. Spots corre-
Molecular diagnosis of mycobacterial susceptibility 417The other key point for treating infections in MSMD
patients is to identify the microorganism responsible for the
infection as early as possible. Because immunodeficient
patients tend to have faster infection progression, the
pathogen must be identified rapidly so that appropriate
antibiotics can be given. In two of our three patients, the
mycobacterial culture produced negative results, which
might be attributable to previous antibiotic treatment. We
hence used an oligonucleotide array to identify the myco-
bacteria and guide the use of antibiotics.
Traditionally, microscopic examination after acid-fast
staining and culture using specific media are the corner-
stones of diagnosis for mycobacterial infections. However,
direct microscopy has lower sensitivity and cannot identify
mycobacterial species. Mycobacterial culture may take up
to weeks because of the slow growth rates of many non-
tuberculosis microorganisms.20 Because timely detection
and identification of mycobacterial species and other slow-
growing microorganisms are important for clinical treat-
ment, DNA-based molecular methods, including the oligo-
nucleotide array technique, have been developed for their
identification.21e23 For our oligonucleotide array test, the
entire testing procedure, including DNA extraction, PCR,
DNA hybridization, and signal detection, can be finished
within 7 hours. The oligonucleotide array should be an
important tool for diagnosing mycobacterial infections in
MSMD patients in the future.
In conclusion, invasive mycobacterial infections are
common in patients with MSMD. The molecular diagnosis of
primary immunodeficiency should be pursued diligently and
oligonucleotide arrays may be a useful and rapid method
for identifying the pathogens in these patients.Acknowledgments
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